Cure My Disease

Don't miss your cure!

 Log in / Sign up

New database aims to crack the code on three rare skin cancers

NCT ID NCT03210935

Recruiting now Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is building a large French database of patients with three rare skin cancers: Merkel cell carcinoma, advanced basal cell carcinoma, and cutaneous adnexal carcinomas. Researchers will track up to 9,000 participants to learn how these cancers behave, what factors affect prognosis, and how different treatments impact outcomes. The goal is to gather real-world evidence to improve future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could provide doctors with better information to predict how these rare skin cancers behave and which treatments work best.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test a new drug or cure, and results may take years to influence patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADNEXAL TUMOR OF SKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

basal cell carcinoma cutaneous neuroendocrine carcinoma epidermal appendage tumor skin appendage carcinoma skin basal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADNEXAL TUMOR OF SKIN ADVANCED BASAL CELL CARCINOMA REQUIRING SYSTEMIC TREATMENT MERKEL CELL CARCINOMA

Contacts and locations

Locations

  • CH Annecy Gennevois

    RECRUITING

    Annecy, France

  • CH Le Mans

    RECRUITING

    Le Mans, Le Mans, 72037, France

  • CHR d'Orleans

    RECRUITING

    Orléans, France

  • CHU Ambroise Paré

    RECRUITING

    Boulogne-Billancourt, France

  • CHU Amiens Picardie

    RECRUITING

    Amiens, France

  • CHU Angers

    RECRUITING

    Angers, France

  • CHU Avicenne

    RECRUITING

    Bobigny, France

  • CHU Besançon

    RECRUITING

    Besançon, France

  • CHU Bichat

    RECRUITING

    Paris, France

  • CHU Bocage

    RECRUITING

    Dijon, Dijon, 21079, France

  • CHU Cochin

    RECRUITING

    Paris, France

  • CHU Nantes - Place Alexis Ricordeau

    RECRUITING

    Nantes, France

  • CHU St Louis

    RECRUITING

    Paris, France

  • CHU de Bordeaux

    RECRUITING

    Pessac, France

  • CHU de Brest

    RECRUITING

    Brest, France

  • CHU de Caen

    RECRUITING

    Caen, France

  • CHU de Clermont Ferrand

    RECRUITING

    Clermont-Ferrand, France

  • CHU de Grenoble

    RECRUITING

    Grenoble, France

  • CHU de Limoges

    RECRUITING

    Limoges, France

  • CHU de Nancy

    RECRUITING

    Nancy, France

  • CHU de Nice

    RECRUITING

    Nice, France

  • CHU de Pointe à Pitre

    RECRUITING

    Pointe à Pitre, France

  • CHU de Poitiers

    RECRUITING

    Poitiers, France

  • CHU de Reims

    RECRUITING

    Reims, France

  • CHU de Rennes

    RECRUITING

    Rennes, France

  • CHU de Rouen

    RECRUITING

    Rouen, France

  • CHU de Strasbourg

    RECRUITING

    Strasbourg, France

  • CHU de Toulouse - Larrey

    RECRUITING

    Toulouse, France

  • CHU de Tours

    RECRUITING

    Tours, France

  • Centre Léon Bérard

    RECRUITING

    Lyon, France

  • Centre hospitalier Lyon Sud

    RECRUITING

    Pierre-Bénite, Pierre-benite, 69495, France

  • Hôpital La Timone

    RECRUITING

    Marseille, France

  • Hôpital St Eloi

    RECRUITING

    Montpellier, France

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.